Word

BASILEA PHARMACEUTICA

Status

Dead

Status Code

606

Status Date

Monday, January 4, 2021

Serial Number

87222044

Mark Type

4000

Filing Date

Tuesday, November 1, 2016

Published for Opposition

Tuesday, October 3, 2017

Abandoned Date

Monday, January 4, 2021

Trademark Owner History

Basilea Pharmaceutica International Ltd. - Owner At Publication

Classifications

1 Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use

5 Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use (Class 001); Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Veterinary products and preparations for the treatment and prevention of infections caused by bacteria, and Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents

42 Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

"PHARMACEUTICA"

Trademark Events

Jan 4, 2021

Abandonment Notice E-Mailed - No Use Statement Filed

Jan 4, 2021

Abandonment - No Use Statement Filed

May 13, 2020

Notice Of Approval Of Extension Request E-Mailed

May 12, 2020

Extension 5 Granted

Apr 30, 2020

Extension 5 Filed

Apr 30, 2020

Teas Extension Received

Oct 26, 2019

Notice Of Approval Of Extension Request E-Mailed

Oct 24, 2019

Extension 4 Granted

Oct 24, 2019

Extension 4 Filed

Oct 24, 2019

Teas Extension Received

May 29, 2019

Notice Of Approval Of Extension Request E-Mailed

May 27, 2019

Extension 3 Granted

May 27, 2019

Extension 3 Filed

May 27, 2019

Teas Extension Received

May 22, 2019

Corrected Noa E-Mailed

May 21, 2019

Divisional Processing Complete

May 3, 2019

Divisional Request Received

May 20, 2019

Case Assigned To Intent To Use Paralegal

May 3, 2019

Teas Request To Divide Received

Nov 2, 2018

Notice Of Approval Of Extension Request E-Mailed

Oct 31, 2018

Extension 2 Granted

Oct 31, 2018

Extension 2 Filed

Oct 31, 2018

Teas Extension Received

May 11, 2018

Notice Of Approval Of Extension Request E-Mailed

May 9, 2018

Extension 1 Granted

May 9, 2018

Extension 1 Filed

May 9, 2018

Teas Extension Received

Nov 28, 2017

Noa E-Mailed - Sou Required From Applicant

Oct 3, 2017

Official Gazette Publication Confirmation E-Mailed

Oct 3, 2017

Published For Opposition

Sep 13, 2017

Notification Of Notice Of Publication E-Mailed

Aug 25, 2017

Approved For Pub - Principal Register

Aug 11, 2017

Teas/Email Correspondence Entered

Aug 10, 2017

Correspondence Received In Law Office

Aug 10, 2017

Teas Response To Office Action Received

Feb 10, 2017

Notification Of Non-Final Action E-Mailed

Feb 10, 2017

Non-Final Action E-Mailed

Feb 10, 2017

Non-Final Action Written

Feb 8, 2017

Assigned To Examiner

Nov 4, 2016

New Application Office Supplied Data Entered In Tram

Nov 4, 2016

New Application Entered In Tram